Results 241 to 250 of about 7,068,825 (349)

Slow growth rate in a rare isolated external iliac aneurysm. [PDF]

J Vasc Surg Cases Innov Tech
York J, Tallarita T, Jabeen N, Almadani Y, Beckerman J, Sen I.   +5 more
europepmc   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Phage-mediated lysis increases growth rate of surviving bacterial cells

Fara E, Raach B, Cavallaro A, Fink J, Ramesh D, Guo Y, Orphan V, Hall AR, Micali G, Ackermann M, Schubert OT.   +10 more
europepmc   +1 more source

Effect of early micro-breastfeeding on growth rate and postpartum depression in preterm infants with low-birth-weight. [PDF]

World J Psychiatry
Chen Y, Cai SL.
europepmc   +1 more source

Intrinsic Rate of Growth

, 2016
Monica Nordberg, Douglas M. Templeton, Ole Andersen, John H. Duffus   +3 more
openalex   +2 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

Growth-Rate Related Quantitative Trait Locus Analysis of Monokaryotic Isolates of <i>Grifola albicans</i> f. <i>huishuhua</i> (Maitake). [PDF]

J Fungi (Basel)
Zhang P, Wang J, Li G, Xiao S, Sun L, Li X, Tian J, Li M, Li S.   +8 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Radiologic Specific Growth Rate of Ameloblastomas: A Clinicopathological Correlation. [PDF]

J Oral Pathol Med
Smit C, Robinson L, van Heerden MB, Meyer PW, Fonseca FP, van Heerden WFP, Uys A.   +6 more
europepmc   +1 more source